NCT05144139View on ClinicalTrials.gov

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

August 28, 2022

Study Completion Date

November 11, 2022

Conditions
COVID-19 Pandemic
Interventions
BIOLOGICAL

COVID-19 mRNA vaccine

Intramuscular injection, COVID-19 mRNA vaccine/placebo, 21 days interval

Trial Locations (1)

01000

Mayfong Mayxay, Vientiane

All Listed Sponsors
lead

Stemirna Therapeutics

INDUSTRY

NCT05144139 - A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above | Biotech Hunter | Biotech Hunter